Skip to main content
. 2020 Feb 14;5:13. doi: 10.1038/s41392-020-0111-4

Fig. 6. Immunohistochemical analyses of MYH9, GSK3β, β-catenin, and HBX expression in HCC.

Fig. 6

a Comparisons of MYH9, GSK3β, and β-catenin expression between HCC and adjacent noncancerous tissues. b Correlations among HBX, MYH9, GSK3β, and β-catenin expression. c Kaplan–Meier survival analysis was performed for HCC patients according to MYH9 expression. d Univariate and multivariate survival analyses of clinicopathological characteristics of hepatocellular carcinoma patients. e Working model of the MYH9/GSK3β/β-catenin-c-Jun regulatory circuit activated by HBX via MYH9-modulated ubiquitination and degradation of GSK3β in Wnt signaling in HCC.